JYOTHYLAB - Investment Analysis
Last Updated Time : 02 Aug 25, 12:58 am
Back to Investment Listπ Investment Analysis: JYOTHY LAB (βΉ332)
Investment Rating: 4.0
JYOTHY LAB exhibits many of the hallmarks of a fundamentally sound business with potential for long-term value creation. Let's unpack the numbers and trends to see where the opportunities and caution flags lie
πΉ Fundamental Strengths
ROCE: 25.1%, ROE: 19.4%
β Very healthy returns β reflects strong capital efficiency and management effectiveness.
PEG Ratio: 0.98
Fairly valued based on growth. PEG < 1 generally indicates a reasonable price for expected earnings growth.
Debt-to-Equity: 0.03
Extremely low leverage β shows financial prudence and stability.
Dividend Yield: 1.05%
Modest dividend, but steady β not a major income play, more a growth+stability candidate.
βοΈ Valuation & Technicals
Current P/E: 32.7 vs Industry P/E: 23.5
Slight premium, but acceptable given the companyβs strong ROCE/ROE.
Book Value: βΉ55.8, EPS: βΉ10.1
Price-to-book is ~6, and Price-to-earnings is in premium zone β not cheap, but not overheated.
DMA 50: βΉ344, DMA 200: βΉ377
Price is below both DMAs β signifies technical weakness, possible accumulation zone developing.
RSI: 37.3, MACD: -1.98
RSI near oversold territory; watch for trend reversal confirmation.
Quarterly Profit Dip (βΌ 1.52%)
Slight drop in PAT β not alarming unless trend continues.
Volume vs Avg Volume: Slightly lower
Indicates lack of strong momentum β good time to evaluate entries rather than chase price.
π― Ideal Entry Price Zone
Entry Range: βΉ290ββΉ315
This aligns with technical supports and offers margin of safety.
Look for confirmation via MACD crossover or RSI recovery toward 45β50.
π£οΈ Exit Strategy / Holding Period
If you're already holding
Holding Period: Long-term (2β5 years) based on strong fundamentals.
Watch For
Continued ROE/ROCE consistency
EPS growth aligning with PEG ratio moderation
Stability in dividend payout and volume expansion
Exit Approach
Target range: βΉ420ββΉ475 assuming growth resumes and technical resistance is breached.
Consider partial profit booking if RSI crosses 70 or P/E exceeds 38β40 without earnings support.
π Verdict
JYOTHY LAB is not a deep value play, but it ticks the boxes for a quality compounder with steady fundamentals and low debt. Ideal for long-term investors who prioritize capital efficiency and consistent growth.
Want to compare this with other FMCG midcaps or visualize trend zones on a chart? I can help you dig deeper.
Edit in a page
Back to Investment List